MET and hepatocellular carcinoma: In liver cancer, miR-93 can negatively regulate the expression of the tumor suppressor gene PTEN, and promote the proliferation, invasion and migration of hepatocellular carcinoma cells by activating the c-Met/PI3K/Akt signaling pathway [15].